US5116964A
(en)
|
1989-02-23 |
1992-05-26 |
Genentech, Inc. |
Hybrid immunoglobulins
|
JP3008208B2
(ja)
*
|
1990-06-01 |
2000-02-14 |
武田薬品工業株式会社 |
新規ハイブリドーマ,その製造法および生理活性物質の製造法
|
GB9022545D0
(en)
*
|
1990-10-17 |
1990-11-28 |
Wellcome Found |
Culture medium
|
US5986067A
(en)
*
|
1991-02-08 |
1999-11-16 |
The University Of Vermont And State Agricultural College |
Recombinant transferrins, transferrin half-molecules and mutants thereof
|
US6825037B1
(en)
|
1991-02-08 |
2004-11-30 |
University Of Vermont |
Recombinant transferrins, transferrin half-molecules and mutants thereof
|
CA2103583C
(en)
*
|
1991-02-08 |
2009-10-13 |
Walter D. Funk |
Recombinant transferrins, transferrin half-molecules and mutants thereof
|
DE4115722A1
(de)
*
|
1991-05-14 |
1992-11-19 |
Boehringer Mannheim Gmbh |
Serumfreies medium zur kultivierung von saeugerzellen
|
CA2123430C
(en)
*
|
1991-12-06 |
2004-02-10 |
Cornelia M. Gorman |
Prohormone convertase transformed cells
|
US6348327B1
(en)
|
1991-12-06 |
2002-02-19 |
Genentech, Inc. |
Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells
|
WO1993013196A2
(en)
*
|
1991-12-24 |
1993-07-08 |
Genzyme Corporation |
Method for increasing recombinant protein production
|
JPH0763363B2
(ja)
*
|
1991-12-25 |
1995-07-12 |
萩原 義秀 |
融合細胞の取得方法
|
US5877016A
(en)
|
1994-03-18 |
1999-03-02 |
Genentech, Inc. |
Human trk receptors and neurotrophic factor inhibitors
|
US5708142A
(en)
|
1994-05-27 |
1998-01-13 |
Genentech, Inc. |
Tumor necrosis factor receptor-associated factors
|
US5705364A
(en)
*
|
1995-06-06 |
1998-01-06 |
Genentech, Inc. |
Mammalian cell culture process
|
US5721121A
(en)
*
|
1995-06-06 |
1998-02-24 |
Genentech, Inc. |
Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein
|
US6656466B1
(en)
|
1995-06-06 |
2003-12-02 |
Genetech, Inc. |
Human tumor necrosis factor—immunoglobulin(TNFR1-IgG1) chimera composition
|
AUPN442295A0
(en)
*
|
1995-07-26 |
1995-08-17 |
Commonwealth Scientific And Industrial Research Organisation |
Regulated autocrine growth of mammalian cells
|
US6451764B1
(en)
|
1995-09-08 |
2002-09-17 |
Genentech, Inc. |
VEGF-related protein
|
US6030945A
(en)
*
|
1996-01-09 |
2000-02-29 |
Genentech, Inc. |
Apo-2 ligand
|
US6998116B1
(en)
|
1996-01-09 |
2006-02-14 |
Genentech, Inc. |
Apo-2 ligand
|
IL126383A0
(en)
|
1996-04-01 |
1999-05-09 |
Genentech Inc |
Apo-2li and apo-3 apoptosis polypeptides
|
US5851984A
(en)
*
|
1996-08-16 |
1998-12-22 |
Genentech, Inc. |
Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
|
US6159462A
(en)
*
|
1996-08-16 |
2000-12-12 |
Genentech, Inc. |
Uses of Wnt polypeptides
|
US6462176B1
(en)
|
1996-09-23 |
2002-10-08 |
Genentech, Inc. |
Apo-3 polypeptide
|
US7696327B1
(en)
|
1997-10-17 |
2010-04-13 |
Genentech, Inc. |
Antibodies to human Toll homologues
|
US6100076A
(en)
*
|
1997-01-31 |
2000-08-08 |
Genentech, Inc. |
O-fucosyltransferase
|
DE69737457T2
(de)
|
1997-01-31 |
2007-11-29 |
Genentech, Inc., South San Francisco |
O-fukosyltransferase
|
US6136569A
(en)
*
|
1997-02-27 |
2000-10-24 |
Genentech, Inc. |
Method of creating a cDNA library enriched in signal sequences
|
US6342369B1
(en)
|
1997-05-15 |
2002-01-29 |
Genentech, Inc. |
Apo-2-receptor
|
US6342220B1
(en)
|
1997-08-25 |
2002-01-29 |
Genentech, Inc. |
Agonist antibodies
|
US6551799B2
(en)
|
1999-12-07 |
2003-04-22 |
Genentech, Inc. |
Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
|
WO1999049039A2
(en)
|
1998-03-23 |
1999-09-30 |
Genentech, Inc. |
GFRα3 AND ITS USES
|
ES2306480T3
(es)
|
1997-09-18 |
2008-11-01 |
Genentech, Inc. |
Polipeptido dcr3, un homologo de tnfr.
|
JP2001522584A
(ja)
|
1997-10-10 |
2001-11-20 |
ジェネンテク・インコーポレイテッド |
Apo−3リガンドポリペプチド
|
EP2033970A3
(en)
|
1997-10-29 |
2009-06-17 |
Genentech, Inc. |
Polypeptides and nucleic acids encoding the same
|
AU1288399A
(en)
|
1997-10-29 |
1999-05-17 |
Genentech Inc. |
Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3
|
ATE364049T1
(de)
|
1997-11-21 |
2007-06-15 |
Genentech Inc |
Mit a33 verwandte antigene und deren pharmazeutische verwendungen
|
US7192589B2
(en)
|
1998-09-16 |
2007-03-20 |
Genentech, Inc. |
Treatment of inflammatory disorders with STIgMA immunoadhesins
|
NZ504548A
(en)
|
1997-12-03 |
2003-06-30 |
Genentech Inc |
Polypeptides and nucleic acids encoding human chordin
|
ZA9811070B
(en)
|
1997-12-08 |
2000-07-03 |
Genentech Inc |
Type I interferons.
|
EP1037995A1
(en)
|
1997-12-08 |
2000-09-27 |
Genentech, Inc. |
Human interferon-epsilon: a type 1 interferon
|
US6455250B1
(en)
*
|
1997-12-11 |
2002-09-24 |
The Regents Of The University Of California |
Endonuclease compositions and methods of use
|
WO1999036535A1
(en)
|
1998-01-15 |
1999-07-22 |
Genentech, Inc. |
Apo-2 ligand
|
EP2050762A3
(en)
|
1998-03-10 |
2009-07-08 |
Genentech, Inc. |
Human cornichon-like protein and nucleic acids encoding it
|
US7026138B1
(en)
|
1998-03-23 |
2006-04-11 |
Genentech, Inc. |
Polynucleotides encoding GFRα3
|
AU3193399A
(en)
|
1998-03-23 |
1999-10-18 |
Genentech Inc. |
Method of selection for genes encoding secreted and transmembrane proteins
|
EP1865061A3
(en)
|
1998-05-15 |
2007-12-19 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
PT1076703E
(pt)
|
1998-05-15 |
2007-10-10 |
Genentech Inc |
''utilizações terapêuticas de polipéptido homólogos de il-17''
|
EP3112468A1
(en)
|
1998-05-15 |
2017-01-04 |
Genentech, Inc. |
Il-17 homologous polypeptides and therapeutic uses thereof
|
US20020172678A1
(en)
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
DK1115863T3
(da)
|
1998-09-22 |
2008-03-31 |
Genentech Inc |
Ucp4
|
US7399751B2
(en)
*
|
1999-11-04 |
2008-07-15 |
Sertoli Technologies, Inc. |
Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells
|
ATE492640T1
(de)
|
1998-11-30 |
2011-01-15 |
Genentech Inc |
Loslösendes protein 5 - ucp5
|
US7342102B2
(en)
|
1998-11-30 |
2008-03-11 |
Genentech, Inc. |
Uncoupling protein 5 (UCP5)
|
EP1820859B9
(en)
|
1998-12-22 |
2009-10-28 |
Genentech, Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
CA2354027A1
(en)
|
1998-12-23 |
2000-07-06 |
Genentech, Inc. |
Il-1 related polypeptides
|
IL145676A0
(en)
|
1999-04-12 |
2002-06-30 |
Genentech Inc |
Tumor necrosis factor homologs and nucleic acids encoding the same
|
EP1956030B1
(en)
|
1999-06-15 |
2009-11-11 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids endoding the same
|
DE60031419T2
(de)
|
1999-08-25 |
2007-09-27 |
Immunex Corp., Thousand Oaks |
Zusammensetzungen und verfahren für verbesserte zellkultur
|
KR100874280B1
(ko)
|
1999-10-20 |
2008-12-18 |
제넨테크, 인크. |
T 헬퍼 세포 매개 질환의 치료를 위한 t 세포 분화의조절
|
CA2492049A1
(en)
|
1999-12-01 |
2001-06-07 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7226591B2
(en)
|
2000-05-22 |
2007-06-05 |
Genentech, Inc. |
Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
|
DK1897945T3
(da)
|
1999-12-23 |
2012-05-07 |
Genentech Inc |
IL-17 homologe polypeptider og terapeutiske anvendelser deraf.
|
EP1757311B1
(en)
|
1999-12-24 |
2009-02-11 |
Genentech, Inc. |
Methods and compositions for prolonging elimination half-times of bioactive compounds
|
CA2390691C
(en)
|
1999-12-24 |
2016-05-10 |
Genentech, Inc. |
Methods and compositions for prolonging elimination half-times of bioactive compounds
|
JP2003519491A
(ja)
|
2000-01-13 |
2003-06-24 |
ジェネンテック・インコーポレーテッド |
新規なstra6ポリペプチド
|
PT1255558E
(pt)
|
2000-02-16 |
2006-11-30 |
Genentech Inc |
Anticorpos anti-april e células hibridoma
|
BR0110610A
(pt)
|
2000-04-11 |
2003-04-29 |
Genentech Inc |
Anticorpos isolados, imunoconjugados, cadeias de polipeptìdeos, ácido nucléico isolado, vetor, célula hospedeira, processo de produção de anticorpo ou cadeia de polipeptìdeos, método de tratamento de disfunções em mamìferos, método de indução da apoptose de uma célula cancerosa, método para matar uma célula b, método para matar uma célula que expresse um receptor de erbb e usos dos anticorpos isolados
|
EP2168980A1
(en)
|
2000-06-23 |
2010-03-31 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogensis
|
EP2042597B1
(en)
|
2000-06-23 |
2014-05-07 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
ATE412009T1
(de)
|
2000-08-24 |
2008-11-15 |
Genentech Inc |
Methode zur inhibierung von il-22 induziertem pap1
|
EP1944317A3
(en)
|
2000-09-01 |
2008-09-17 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US6673580B2
(en)
|
2000-10-27 |
2004-01-06 |
Genentech, Inc. |
Identification and modification of immunodominant epitopes in polypeptides
|
JP4656814B2
(ja)
|
2000-12-20 |
2011-03-23 |
エフ.ホフマン−ラ ロシュ アーゲー |
エリスロポエチンコンジュゲート
|
US7087726B2
(en)
|
2001-02-22 |
2006-08-08 |
Genentech, Inc. |
Anti-interferon-α antibodies
|
IL157993A0
(en)
*
|
2001-03-23 |
2004-03-28 |
Napro Biotherapeutics Inc |
Molecular conjugates for use in cancer treatment and methods for the preparation thereof
|
KR20040032105A
(ko)
*
|
2001-06-04 |
2004-04-14 |
엠엘 래보러토리즈 피엘씨 |
재조합 단백질의 조성물 및 재조합 단백질의 고수준대규모 생산방법
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
EP1992643A3
(en)
|
2001-06-20 |
2008-12-10 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
ES2386346T3
(es)
|
2001-08-29 |
2012-08-17 |
Genentech, Inc. |
Ácidos nucleicos y polipéptidos Bv8 con actividad mitógena
|
KR101008758B1
(ko)
|
2001-09-18 |
2011-01-14 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
|
MXPA04006554A
(es)
|
2002-01-02 |
2005-03-31 |
Genentech Inc |
Composiciones y metodos para diagnostico y tratamiento de tumor.
|
US7164002B2
(en)
|
2002-02-06 |
2007-01-16 |
Genentech, Inc. |
FVIIa antagonists
|
CA2476518A1
(en)
|
2002-02-22 |
2003-09-04 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
NZ535925A
(en)
|
2002-04-16 |
2008-06-30 |
Genentech Inc |
An isolated antibody that binds to a particular polypeptide
|
WO2004004649A2
(en)
|
2002-07-08 |
2004-01-15 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
US20060281146A1
(en)
|
2002-09-11 |
2006-12-14 |
Genetech, Inc. |
Novel compositions and methods for the treatment of immune related diseases
|
AU2003276874B2
(en)
|
2002-09-11 |
2009-09-03 |
Genentech, Inc. |
Novel compositions and methods for the treatment of immune related diseases
|
EP1539228B1
(en)
|
2002-09-11 |
2010-12-29 |
Genentech, Inc. |
Novel composition and methods for the treatment of immune related diseases
|
EP1578364A4
(en)
|
2002-09-16 |
2011-06-08 |
Genentech Inc |
COMPOSITIONS AND METHODS FOR TREATING IMMUNE DISEASES
|
EP2500438A3
(en)
|
2002-09-25 |
2012-11-28 |
Genentech, Inc. |
Novel compositions and methods for the treatment of psoriasis
|
AU2003298607B9
(en)
|
2002-10-29 |
2011-08-04 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
CA2503748A1
(en)
|
2002-11-08 |
2004-05-27 |
Genentech, Inc. |
Compositions and methods for the treatment of natural killer cell related diseases
|
JP2011516026A
(ja)
|
2002-11-26 |
2011-05-26 |
ジェネンテック・インコーポレーテッド |
免疫関連疾患の治療のための組成物と方法
|
RU2377253C2
(ru)
*
|
2002-12-02 |
2009-12-27 |
Амген Фремонт,Инк. |
Антитела, специфичные к фактору некроза опухолей, и их применение
|
KR101294959B1
(ko)
|
2003-03-12 |
2013-08-09 |
제넨테크, 인크. |
조혈을 촉진하기 위한 bv8 및(또는) eg-vegf의 용도
|
RU2332986C2
(ru)
|
2003-04-04 |
2008-09-10 |
Дженентек, Инк. |
Высококонцентрированные композиции антител и белков
|
CA2531022C
(en)
*
|
2003-07-03 |
2014-09-09 |
Jannette Dufour |
Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants
|
SI1641822T1
(sl)
|
2003-07-08 |
2013-08-30 |
Genentech, Inc. |
IL-17 A/F heterologni polipeptidi in njihove terapevtske uporabe
|
WO2005019258A2
(en)
|
2003-08-11 |
2005-03-03 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
EP2301568A1
(en)
|
2003-11-17 |
2011-03-30 |
Genentech, Inc. |
Antibody against IRTA2 for the treatment of tumour of hematopoietic origin
|
NZ563341A
(en)
|
2005-06-06 |
2009-10-30 |
Genentech Inc |
Methods for identifying agents that modulate a gene that encodes for a PRO1568 polypeptide
|
CN101300342A
(zh)
*
|
2005-11-02 |
2008-11-05 |
惠氏公司 |
用于使哺乳动物细胞具备适应性的方法
|
US20070231895A1
(en)
*
|
2005-11-02 |
2007-10-04 |
Lee Gene W |
Methods for adapting mammalian cells
|
ES2618543T3
(es)
|
2005-11-23 |
2017-06-21 |
Genentech, Inc. |
Métodos y composiciones relacionados con ensayos de linfocitos B
|
US20070190057A1
(en)
|
2006-01-23 |
2007-08-16 |
Jian Wu |
Methods for modulating mannose content of recombinant proteins
|
EP2614839A3
(en)
|
2006-04-05 |
2015-01-28 |
Genentech, Inc. |
Method for using BOC/CDO to modulate hedgehog signaling
|
JP2009536022A
(ja)
|
2006-04-19 |
2009-10-08 |
ジェネンテック・インコーポレーテッド |
新規の遺伝子破壊、それに関連する組成物および方法
|
AU2007244683A1
(en)
|
2006-04-27 |
2007-11-08 |
Pikamab, Inc. |
Methods and compositions for antibody therapy
|
WO2008019214A1
(en)
|
2006-08-04 |
2008-02-14 |
Prolong Pharmaceuticals, Inc. |
Modified erythropoietin
|
WO2008033890A2
(en)
|
2006-09-12 |
2008-03-20 |
Beth Israel Deaconess Medical Center, Inc. |
Compositions containing alpha-1-antitrypsin and methods for use
|
CA2668208C
(en)
|
2006-11-02 |
2017-09-12 |
Daniel J. Capon |
Hybrid immunoglobulins with moving parts
|
WO2008115039A1
(en)
|
2007-03-22 |
2008-09-25 |
Industry Academic Cooperation Foundation, The Catholic University Of Korea |
Novel use of ec-sod and method for preparing thereof
|
US9089564B2
(en)
|
2007-03-22 |
2015-07-28 |
The Catholic University of Korea Industry-Academic Cooperatior |
Use of EC-SOD for treating angiogenesis-mediated eye diseases
|
PT3597659T
(pt)
|
2007-07-09 |
2023-04-04 |
Genentech Inc |
Prevenção da redução de ligações de dissulfureto durante a produção recombinante de polipéptidos
|
PT2207790E
(pt)
|
2007-09-05 |
2013-11-04 |
Genentech Inc |
Péptidos que contêm arginina c-terminal biologicamente ativos
|
EP2235063B1
(en)
|
2007-12-28 |
2015-09-02 |
Genentech, Inc. |
Anti-hedgehog antibodies
|
CA2720610C
(en)
|
2008-04-07 |
2016-08-23 |
Bayer Healthcare Llc |
Methods of recombinant production of glycoproteins
|
AU2008360729A1
(en)
|
2008-08-18 |
2010-02-25 |
Seoul National University Industry Foundation |
Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl tRNA synthetase
|
AU2009290563A1
(en)
|
2008-09-15 |
2010-03-18 |
Genentech, Inc. |
Compositions and methods for regulating cell osmolarity
|
KR101102485B1
(ko)
|
2008-10-10 |
2012-01-05 |
서울대학교산학협력단 |
Grs단백질 또는 이의 단편의 신규한 용도
|
AU2009333580B2
(en)
|
2008-12-09 |
2016-07-07 |
Genentech, Inc. |
Anti-PD-L1 antibodies and their use to enhance T-cell function
|
IL264336B2
(en)
|
2009-08-11 |
2024-02-01 |
Genentech Inc |
Production of proteins in cell culture medium without glutamine
|
CN102712688B
(zh)
|
2009-09-23 |
2015-06-24 |
通益制药有限公司 |
重组人红细胞生成素(epo)的纯化方法、由此纯化的epo以及包含纯化的epo的药物组合物
|
SG10201408598XA
(en)
|
2009-11-30 |
2015-02-27 |
Genentech Inc |
Antibodies for treating and diagnosing tumors expressing slc34a2 (tat211 = seqid2 )
|
CN107090045A
(zh)
|
2010-05-03 |
2017-08-25 |
霍夫曼-拉罗奇有限公司 |
用于肿瘤诊断和治疗的组合物和方法
|
EA030418B1
(ru)
|
2010-07-12 |
2018-08-31 |
ЭйТИР ФАРМА, ИНК. |
ТЕРАПЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ДЛЯ ЛЕЧЕНИЯ ВОСПАЛИТЕЛЬНОГО ЗАБОЛЕВАНИЯ, ПОЛИПЕПТИД АМИНОАЦИЛ-тРНК-СИНТЕТАЗЫ (AARS)
|
KR20130100125A
(ko)
|
2010-08-13 |
2013-09-09 |
제넨테크, 인크. |
질환의 치료를 위한, IL-1β 및 IL-18에 대한 항체
|
WO2012075238A1
(en)
|
2010-12-02 |
2012-06-07 |
Genentech, Inc. |
Novel receptor-ligand interaction and uses thereof
|
WO2012088383A2
(en)
|
2010-12-23 |
2012-06-28 |
Genentech, Inc. |
PILR alpha INTERACTIONS AND METHODS OF MODIFYING SAME
|
CN102586190B
(zh)
*
|
2011-01-11 |
2014-01-01 |
北京华安科创生物技术有限公司 |
高效表达重组人神经生长因子的cho细胞株及其构建方法
|
WO2013077534A1
(en)
|
2011-11-23 |
2013-05-30 |
Cell Biotech Co., Ltd. |
Protein p14 with anti-cancer and anti-allergy activity and pharmaceutical composition comprising the same
|
WO2013090915A1
(en)
|
2011-12-16 |
2013-06-20 |
Braskem S.A. |
Modified microorganisms and methods of making butadiene using same
|
RU2659423C2
(ru)
|
2012-02-16 |
2018-07-02 |
ЭйТИР ФАРМА, ИНК. |
ГИСТИДИЛ-тРНК-СИНТЕТАЗЫ ДЛЯ ЛЕЧЕНИЯ АУТОИММУННЫХ И ВОСПАЛИТЕЛЬНЫХ ЗАБОЛЕВАНИЙ
|
US9493744B2
(en)
|
2012-06-20 |
2016-11-15 |
Genentech, Inc. |
Methods for viral inactivation and other adventitious agents
|
US20130281355A1
(en)
|
2012-04-24 |
2013-10-24 |
Genentech, Inc. |
Cell culture compositions and methods for polypeptide production
|
US9550818B2
(en)
|
2012-04-27 |
2017-01-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods for use of vascular endothelial growth factor antagonists
|
EP2749569A1
(en)
*
|
2012-12-28 |
2014-07-02 |
Annibale Alessandro Puca |
Variant of BPIFB4 protein
|
PL2970875T3
(pl)
|
2013-03-15 |
2020-08-10 |
F.Hoffmann-La Roche Ag |
Kompozycje do hodowli komórkowych z przeciwutleniaczami i sposoby wytwarzania polipeptydów
|
JP6397479B2
(ja)
|
2013-03-15 |
2018-09-26 |
エータイアー ファーマ, インコーポレイテッド |
ヒスチジル−tRNAシンテターゼFcコンジュゲート
|
CA2902288A1
(en)
|
2013-03-15 |
2014-09-18 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Use of tricarboxylic acid (tca) intermediates to control ammonia generation in cell culture
|
ES2759061T3
(es)
|
2013-03-15 |
2020-05-07 |
Biomolecular Holdings Llc |
Inmunoglobulina híbrida que contiene unión no peptidílica
|
EP2829608A1
(en)
|
2013-07-23 |
2015-01-28 |
Universität Bielefeld |
Method for recombinant protein production in mammalian cells
|
BR112016006321B1
(pt)
|
2013-09-23 |
2022-11-16 |
Braskem S.A |
Enzima engenheirada tendo especificidade de substrato aceto acetil-coa e atividade aceto acetil-coa específica de hidrolase, micro-organismo modificado, e, processo de produção de um ou mais produtos a partir de uma fonte de carbono fermentável
|
WO2015073633A1
(en)
|
2013-11-15 |
2015-05-21 |
Genentech, Inc. |
Methods for viral inactivation using eco-friendly detergents
|
BR112016017660B1
(pt)
|
2014-02-27 |
2022-04-19 |
F. Hoffmann-La Roche Ag |
Método para a produção de uma glicoproteína recombinante
|
CN106456574A
(zh)
|
2014-03-14 |
2017-02-22 |
丹尼尔·J·卡鹏 |
含有非肽连接的杂合免疫球蛋白
|
AU2015243961A1
(en)
|
2014-04-10 |
2016-10-27 |
Bayer Healthcare Llc |
Compounded media powder formulation and method of preparation of liquid medium for cell culture
|
KR101619863B1
(ko)
|
2014-05-23 |
2016-05-24 |
주식회사 제노포커스 |
신규 베타-갈락토시다아제
|
US11345908B2
(en)
|
2014-05-30 |
2022-05-31 |
Braskem S.A. |
Modified microorganisms comprising an optimized system for oligosaccharide utilization and methods of using same
|
KR101730035B1
(ko)
|
2015-03-20 |
2017-04-26 |
한국과학기술원 |
L-아스파르트산 유도체를 생산하는 변이미생물 및 이를 이용한 l-아스파르트산 유도체의 제조방법
|
KR101839595B1
(ko)
|
2015-04-13 |
2018-04-26 |
한국과학기술원 |
락탐의 제조방법
|
KR20160141123A
(ko)
|
2015-05-28 |
2016-12-08 |
주식회사 제노포커스 |
고당전이 활성의 베타-갈락토시다제 변이체 및 그 용도
|
KR101702906B1
(ko)
|
2015-07-15 |
2017-02-22 |
주식회사 제노포커스 |
신규 알파-1,3-글루카나제
|
TWI797060B
(zh)
|
2015-08-04 |
2023-04-01 |
美商再生元醫藥公司 |
補充牛磺酸之細胞培養基及用法
|
KR101756338B1
(ko)
|
2016-01-15 |
2017-07-10 |
고려대학교 산학협력단 |
L-시스테인 생산용 변이미생물 및 이를 이용한 l-시스테인의 제조방법
|
CA3032512A1
(en)
|
2016-08-02 |
2018-02-08 |
Vaccinex, Inc. |
Improved methods for producing polynucleotide libraries in vaccinia virus/eukaryotic cells
|
EP3339444A1
(en)
|
2016-12-20 |
2018-06-27 |
Mabxience Research, S.L. |
Method for obtaining a glycoprotein with an increased percentage of afucosylated glycans
|
US11767520B2
(en)
|
2017-04-20 |
2023-09-26 |
Atyr Pharma, Inc. |
Compositions and methods for treating lung inflammation
|
CN111936625A
(zh)
|
2018-03-29 |
2020-11-13 |
豪夫迈·罗氏有限公司 |
调节哺乳动物细胞中的生乳活性
|
KR102658830B1
(ko)
|
2018-08-02 |
2024-04-19 |
에스케이이노베이션 주식회사 |
내열성 탄산무수화효소 변이체 및 이를 포함하는 이산화탄소 포집용 조성물
|
AR117327A1
(es)
|
2018-12-20 |
2021-07-28 |
23Andme Inc |
Anticuerpos anti-cd96 y métodos de uso de estos
|
BR112021010374A2
(pt)
|
2018-12-21 |
2021-08-24 |
23Andme, Inc. |
Anticorpos anti-il-36 e métodos de uso dos mesmos
|
KR102346050B1
(ko)
|
2019-01-25 |
2022-01-03 |
주식회사 네오믹스 |
미백 활성을 갖는 신규 폴리펩타이드 및 이의 용도
|
BR112022020899A2
(pt)
|
2020-04-15 |
2022-12-27 |
Genentech Inc |
Método para tratamento de um meio de cultura celular, meio de cultura celular, uso do meio e método para produzir uma proteína recombinante
|
CN116323665A
(zh)
|
2020-05-29 |
2023-06-23 |
23和我公司 |
抗cd200r1抗体及其使用方法
|
CN116234824A
(zh)
|
2020-06-22 |
2023-06-06 |
阿尔米雷尔有限公司 |
抗il-36抗体及其使用方法
|
US20220041672A1
(en)
|
2020-06-24 |
2022-02-10 |
Genentech, Inc. |
Apoptosis resistant cell lines
|
AR123158A1
(es)
|
2020-08-07 |
2022-11-02 |
Genentech Inc |
Proteínas de fusión del ligando para flt3 y métodos de uso
|
JP2023539201A
(ja)
|
2020-08-28 |
2023-09-13 |
ジェネンテック, インコーポレイテッド |
宿主細胞タンパク質のCRISPR/Cas9マルチプレックスノックアウト
|
WO2022050521A1
(ko)
|
2020-09-07 |
2022-03-10 |
주식회사 지아이셀 |
Ace2 결합력이 감소된 코로나바이러스 유래 수용체 결합 도메인 변이체 및 이를 포함하는 백신 조성물
|
KR20220059399A
(ko)
|
2020-11-02 |
2022-05-10 |
한국과학기술원 |
소수성 물질의 생산능이 향상된 재조합 미생물 및 이의 제조를 위한 세포막 엔지니어링 방법
|
CA3200954A1
(en)
|
2020-11-16 |
2022-05-19 |
F. Hoffmann-La Roche Ag |
Fab high mannose glycoforms
|
KR102661294B1
(ko)
|
2020-12-24 |
2024-04-30 |
한국과학기술원 |
글루타르산 수송체 유전자가 도입된 재조합 미생물 및 이를 이용한 글루타르산의 제조방법
|
EP4326855A1
(en)
|
2021-04-19 |
2024-02-28 |
Genentech, Inc. |
Modified mammalian cells
|
CN117813504A
(zh)
|
2021-06-04 |
2024-04-02 |
基因泰克公司 |
对蛋白质样品中的残留宿主细胞蛋白质的鉴定和定量
|
CN117916594A
(zh)
|
2021-09-15 |
2024-04-19 |
基因泰克公司 |
代谢组学分析
|
WO2024129594A1
(en)
|
2022-12-12 |
2024-06-20 |
Genentech, Inc. |
Optimizing polypeptide sialic acid content
|